How effective is JAK inhibitor treatment for alopecia totalis?

Alopecia totalis involves loss of hair across the scalp. A JAK inhibitor works by reducing immune signals that can disrupt hair follicles. Improvement may appear as fine or patchy regrowth before hair becomes denser, and some people have little or no visible response. Regrowth can be lost when treatment is stopped, so a dermatologist assesses whether benefit is continuing and whether the medicine remains appropriate.

Effectiveness is judged by changes such as scalp coverage, new hair growth, shedding, and the effect on daily life. Eyebrow, eyelash, and body-hair regrowth may not follow the same pattern as scalp regrowth. The diagnosis, duration of hair loss, other health conditions, and the specific medicine all influence the discussion.

Arrange a dermatology review to confirm the diagnosis and discuss whether a JAK inhibitor fits your medical history. Before treatment, tell the clinician about infections, pregnancy or plans for pregnancy, medicines, and previous blood-count or liver problems. Follow the prescribed schedule, attend requested blood tests, and report new symptoms rather than changing the dose yourself. Gentle scalp care and cosmetic options can support comfort while response is being assessed.

Contact your treating clinician promptly for fever, a persistent cough, painful skin lesions, unusual bruising, severe fatigue, or symptoms of a new infection while taking a JAK inhibitor. Seek urgent care for trouble breathing, swelling of the face or throat, sudden chest pain, or sudden weakness. Rapidly worsening scalp inflammation, pain, or scaling also deserves review because it may signal a different or additional scalp problem.

Ask which outcome will be used to assess your response, when reassessment is planned, how long treatment may continue, what monitoring is required, and what alternatives can help if regrowth is limited or fades.